Breast cancer--which patients?

The question of which breast cancer patients to treat has been addressed by reviewing posters presented at the International Symposium on Endocrine Therapy. To date, tamoxifen therapy is the dominant type of adjuvant treatment in postmenopausal patients. The most promising results have been obtained in node-positive disease where the effect may be influenced by the receptor status, although this may depend on the cut-off level used.